DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Rapoport AM, Ramadan NM, Adelmann JU. et al, on behalf of The 017 Clinical Trial Study Group.
Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose-finding study.
Neurology 1997; 49: 1210-1218
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.